Highlander Capital Management, LLC Bio N Tech Se Transaction History

Highlander Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$126.25 - $231.85 $37,875 - $69,555	-300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $41,186 - $89,446	-200 Reduced 40.0%	300 $82,000
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $42,865 - $59,750	500 New	500 $55,000
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $36,355 - $64,769	-500 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$57.81 - $104.17 $28,905 - $52,085	500 New	500 $35,000

326

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.